Meridian bioscience stock.

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 Thousand dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.Company profile page for Meridian Bioscience Corp including stock price, company news, press releases, executives, board members, and contact information10 jan. 2018 ... Meridian Bioscience sued over stock drop, diligence in buying lead blood-test firm ... An untold number of children across America might want to ...

2 août 2022 ... ... stock starting 7 June. Meridian Bioscience develops, produces, markets, and distributes a range of diagnostic products in areas that include ...Jul 8, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ... Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Meridian Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]

The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.As a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ...

Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $0.Meridian Bioscience, Inc. (NASDAQ:VIVO) announced its quarterly earnings results on Friday, November, 12th. The company reported $0.24 EPS for the quarter, ...Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Products. Diagnostic assays that deliver the best patient outcomes rely on high-quality reagents. Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 disease targets and an extensive range of specialty qPCR master mixes and molecular enzymes manufactured under ISO13485 ...

Find contact information for Meridian Bioscience. Learn about their Medical Devices & Equipment, Manufacturing market share, competitors, and Meridian Bioscience's email format. Company Overview. ... Stock Symbol. NASDAQ: VIVO. Meridian Bioscience Executive Team & Key Decision Makers. Name & Title Social Contact Info; Lourdes …

Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information.

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues …Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] at the universe of stocks we cover at Dividend Channel, on 5/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, …Meridian Bioscience Inc. (VIVO) Stock Price, News & Historical Data - TheStreet November 26, 2023 [ Healthcare ] [ Medical Diagnostics & Research ] [ VIVO ] …Products. Diagnostic assays that deliver the best patient outcomes rely on high-quality reagents. Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 disease targets and an extensive range of specialty qPCR master mixes and molecular enzymes manufactured under ISO13485 ...Meridian Bioscience Inc stock price live 33.97, this page displays NASDAQ VIVO stock exchange data. View the VIVO premarket stock price ahead of the market session or …

100% technical buy signals. 8 new highs and up 15.79% in the last month. 4,910 investors are monitoring the stock on Seeking Alpha. ... Meridian Bioscience, Inc., a life science company ...12 déc. 2022 ... ... will revise the expected date of acquiring stocks and investment securities of Meridian Bioscience from Jan. 7 to Jan. 31, 2023."This is a.Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...37.23M. MSFT. 378.61. +0.31%. 20.54M. View today's Meridian Bioscience Inc stock price and latest VIVO news and analysis. Create real-time notifications to follow any changes in the live stock price. 7 juil. 2022 ... ... Meridian Bioscience Inc., a Nas. ... stock price on the day before the consortium's first offer before ...Jul 7, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...

Mr. Anderson VIVO stock SEC Form 4 insiders trading. James has made over 3 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 8,500 units of VIVO stock worth $173,230 on 6 January 2023.. The largest trade he's ever made was buying 10,000 units of Meridian …

Company profile page for Meridian Bioscience Inc including stock price, company news, press releases, executives, board members, and contact information Company profile page for Meridian Bioscience Inc including stock price, company news, press releases, executives, board members, and contact information 2 Mei 2022 ... One of Cincinnati's largest public companies names new C-suite member · This Cincinnati company was most popular pick in annual stock contest.Discover historical prices for SLM stock on Yahoo Finance. View daily, weekly or monthly format back to when SLM Corporation stock was issued.May 3, 2019 · View %COMPANY_NAME% VIVO investment & stock information. Get the latest %COMPANY_NAME% VIVO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Meridian Bioscience Inc ... Meridian Bioscience, Inc. (NasdaqGS:VIVO) agreed to acquire Exalenz Bioscience Ltd (TASE:EXEN) from Mori Arkin and others for approximately ILS 170 million on February 19, 2020. According to the agreement, an inverted triple merger will be carried out, where for each share of Exalenz, the buyer will pay ILS 6.1 per share in cash.Find the latest Meridian Bioscience, Inc. (VIVO) stock quote, history, news and other vital information to help you with your stock trading and investing.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]

17 Nov 2022 ... Curian® Campy offers clinicians accurate and timely results to deliver appropriate care for patients infected with campylobacteriosis.

Stock Total Return Performance. The graph below compares the cumulative. 5-Year. total return realized by shareholders on Meridian Bioscience, Inc.'s common ...Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] Bioscience hits 52-week high; stock up 36% YTD SA News Wed, Jun. 08, 2022 2 Comments. Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests22 nov. 2022 ... Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Meridian Bioscience Inc (VIVO) using our online tools.All series of Meridian Bioscience, Inc. options whose expiration dates are after 02-17-2023 will have their expiration dates advanced to 02-17-2023. Expiration dates occurring before 02-17-2023 (e.g., Flex options) will remain unchanged. All Meridian Bioscience, Inc. options will utilize a $.01 exercise threshold. Option Symbol: VIVOMeridian Bioscience Inc. (VIVO) Stock Price, News & Historical Data - TheStreet November 26, 2023 [ Healthcare ] [ Medical Diagnostics & Research ] [ VIVO ] …Oct 10, 2017 · l28988ae10vk.htm MERIDIAN BIOSCIENCE, INC. 10-K. MERIDEIAN BIOSCIENCE, INC. 10-K. Washington, D.C. 20549. FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2007.North Billerica, MA. •Assists customers with the implementation of systems purchased from Meridian Bioscience. •Provide technical product support as well as product training to external and ...Stock Total Return Performance. The graph below compares the cumulative. 5-Year. total return realized by shareholders on Meridian Bioscience, Inc.'s common ...Jul 7, 2022 · SD Biosensor and SJL Partners agreed to acquire Meridian Bioscience in an all-cash deal valued at about $1.53 billion, according to a statement by Cincinnati-based Meridian on Thursday. SD Biosensor, a diagnostics company headquartered in South Korea, along with private equity firm SJL Partners, would create a new affiliate for the deal ... Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least $1.07 Million dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over $958,769 and over the last 14 years he sold VIVO stock worth over $0. In addition, he makes $114,667 as Independent Director at Meridian Bioscience.Jan 31, 2023 · John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...The opportunity to support authentic relationships is what motivates our teams to create accurate solutions that span the range from discovery to diagnosis. We work hard every day to build genuine connections with all of our customers because even in the complex world of healthcare, the solution is simple. We’re here to help people, and we ...Jan 30, 2023 · Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B ... Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Instagram:https://instagram. biglostwhere can i buy shiba inucovered call etfsmullen ev Nov 20, 2018 · Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …Dec 13, 2022 · A high-level overview of Meridian Bioscience, Inc. (VIVO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. best health insurance for young singlesverizon wireless s23 ultra Find the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more. roundhill meme etf Meridian Bioscience Stock Hits New 52-Week High (VIVO) thestreet.com - March 26 at 5:22 PM Phoenix Union Bioscience High School usnews.com - March 23 at 3:29 PM Global "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027 marketwatch.com - March 20 at 6:42 PM Jan 31, 2023 · Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners ... Dec 12, 2022 · Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer ...